Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01911091 · ClinicalTrials.gov registry record · NA

Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)

A NA study of Obesity and Metabolic Disorder, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT01911091 is a NA study of Obesity and Metabolic Disorder that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 56 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01911091, a NA study of Obesity and Metabolic Disorder, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect data to help researchers identify factors, such as certain proteins or genetic codes, that are secreted from muscle that are associated with the beneficial effects of exercise.

Interventions

  • BEHAVIORAL Exercise

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2013-07
Est. Completion 2025-12
Phase NA

What the Registry Record Tells You About NCT01911091

The ClinicalTrials.gov registry entry for NCT01911091 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT01911091 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01911091 about?

NCT01911091 is a clinical study titled "Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)". The purpose of this study is to collect data to help researchers identify factors, such as certain proteins or genetic codes, that are secreted from muscle that are associated with the beneficial effects of exercise.

What is the current status of trial NCT01911091?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2013-07. Estimated completion is 2025-12.

What conditions does trial NCT01911091 study?

This clinical trial studies the following conditions: Obesity, Metabolic Disorder, Lipid Metabolism Disorders, Disorder of Lipid Storage and Metabolism.

What interventions are being tested in trial NCT01911091?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01911091?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01911091 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.